The Scientist - Home

Biotech investment banker predicts market will rebound and tips systems biology as hot area for investment.

Short on votes, US Senate cloning opponent considers proposing a two-year moratorium.

Resignation of COPUS head prompts MPs to ask whether Royal Society has obstructed development of the body.

New initiative aims to develop a vaccine against the HIV subtype most prevalent in Africa.

British scientists warn pressure to halt the use of GM animals in research could stall medical progress

I3C hopes to make identifying and tracking genes and proteins easier, and to encourage open-source software in bioinformatics.

Former Greenpeace director opens BIO 2002 conference with a scathing attack on group's antiscientific approach.

A scientist at the University of Kansas Medical Center, Kansas City, Kans., pleaded guilty in May in a case involving theft of research materials from the Cleveland Clinic Foundation in Ohio. In a plea bargain with prosecutors, Hiroaki Serizawa, an assistant professor of biochemistry at KUMC, admitted he lied to FBI agents who were investigating the theft of DNA, cell line reagents, and other genetic research materials used in Alzheimer research at the Cleveland Clinic. Officials say that the 19

The newly elected members and foreign associates of the National Academy of Sciences (NAS) represent 64 scientific fields manifesting the ever-shifting boundaries of science. Stephen Berry, home secretary of the NAS, says the new class reflects the expansion of science into several new directions; computer and information sciences, biophysics, and human environmental sciences were added a year ago. "All the new and expanded areas correspond to new areas or lie within the bounds of traditional fi

Can the United States cope with biological terrorism? The anthrax deaths have invested this question with new urgency, eliciting many opinions at the Pentagon and in Washington's think tanks. But the dubious benefit of prior experience on which to base those opinions is scarce. One way to get the experience is by the technological play-acting known as simulation. The US Army has used virtual reality simulations for combat training since the late 1980s. Trainees are placed inside a module, three

In patients with progressive external ophthalmoplegia (PEO), the muscles that move the eyes gradually deteriorate until the only way patients can follow an object is by turning their heads. Last year, Christine Van Broeckhoven and colleagues at the University of Antwerp, Belgium, linked PEO in a Belgian family to a point mutation in the gene for polymerase gamma, the DNA polymerase responsible for replicating the 16.5-kilobase mitochondrial chromosome.1 Now, William Copeland's lab at the Nationa

A classical sculpture depicts the Greek Titan Atlas bent awkwardly under the weight of an immense globe. The same sculptor might depict Mariano Barbacid, director of Spain's National Center for Cancer Research (CNIO), carrying an additional weight: Time. Like other Spanish scientists who have returned from the United States and Europe to build their country's biomedical research system, Barbacid must push time forward to an age when Spain attracts legions of Titans in the life sciences. In the